Importantly, we demonstrated that in vivo ablation of Ccrk simultaneously circumvents these metabolic and lipogenic mTORC1-dependent cascades to diminish hepatic lipid accumulation, glucose intolerance, insulin resistance, and HCC tumorigenicity (Fig. 5). Here, CDK20 is linked to hepatocellular carcinoma.